-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Making the Jump - Careers Outside Academia

Program: Special-Interest Sessions
Session: Symposium for Mid-Career Hematologists
Hematology Disease Topics & Pathways:
Workforce
Sunday, December 8, 2024, 4:30 PM-6:00 PM

David P. Steensma, MD

Ajax Therapeutics, Cambridge, MA

Disclosures: Steensma: Ajax Therapeutics: Current Employment; Arrowhead: Divested equity in a private or publicly-traded company in the past 24 months; Gamida Cell: Divested equity in a private or publicly-traded company in the past 24 months; Bluebird Bio: Divested equity in a private or publicly-traded company in the past 24 months; Novartis Pharmaceuticals: Ended employment in the past 24 months.

See more of: Symposium for Mid-Career Hematologists
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>